Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The insulin secretion pathway is the series of molecular and cellular events by which pancreatic β-cells detect increased blood glucose and respond by releasing insulin. This process involves glucose uptake, metabolism, ATP production, KATP channel closure, membrane depolarization, calcium influx, and insulin granule exocytosis. It is essential for maintaining glucose homeostasis, and dysfunction in this pathway is central to the development of diabetes mellitus.
Varies depending on the specific drug and its target within the pathway. Examples: Sulfonylureas close KATP channels, GLP-1 agonists activate GLP-1 receptors.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Insulin Secretion Pathway.